ARK Investment Management LLC Sells 175,329 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)

ARK Investment Management LLC cut its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,163,118 shares of the company’s stock after selling 175,329 shares during the quarter. CRISPR […]

Related Keywords

Canada , ,Pinnacle Holdings ,Eversource Wealth Advisors ,Royal Bank ,Securities Exchange Commission ,Geneos Wealth Management Inc ,Ark Investment Management ,Needham Company ,Investment Management ,Therapeutics Company Profile ,Free Report ,Wealth Management ,Source Wealth Advisors ,Get Free Report ,Crispr Therapeutics ,Nasdaq Crsp ,Crsp ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,